Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
368
datasets available to search
ShareScore release 0.9.0
Dataset results
368 results for “ranibizumab”
Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy (vPDT)
ClinicalTrials.gov study NCT01846273. IPD Sharing: NO. Countries: 7. Publications: 4.
Effect of Ranibizumab on Malignant Conjunctival Neoplasia
ClinicalTrials.gov study NCT00456495. IPD Sharing: NO. Countries: 1. Publications: 1.
Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema
ClinicalTrials.gov study NCT00444600. IPD Sharing: Not stated. Countries: 1. Publications: 17.
A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration
ClinicalTrials.gov study NCT03677934. IPD Sharing: YES. Countries: 1. Publications: 7.
Changes in Retinal Function After Intravitreal Ranibizumab for Age-related Macular Degeneration
ClinicalTrials.gov study NCT00539734. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab
ClinicalTrials.gov study NCT01810042. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
ClinicalTrials.gov study NCT01627249. IPD Sharing: Not stated. Countries: 1. Publications: 22.
Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus
ClinicalTrials.gov study NCT01171976. IPD Sharing: Not stated. Countries: 13. Publications: 1.
Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration
ClinicalTrials.gov study NCT00284089. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization
ClinicalTrials.gov study NCT00436553. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00433017. IPD Sharing: Not stated. Countries: 12. Publications: 2.
A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema
ClinicalTrials.gov study NCT01994291. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
ClinicalTrials.gov study NCT01396057. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab
ClinicalTrials.gov study NCT01292798. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Comparison of Ranibizumab and Aflibercept for the Development of Geographic Atrophy in (Wet) AMD Patients
ClinicalTrials.gov study NCT02130024. IPD Sharing: NO. Countries: 1. Publications: 2.
Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab
ClinicalTrials.gov study NCT02559180. IPD Sharing: NO. Countries: 1. Publications: 7.
A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered
ClinicalTrials.gov study NCT04503551. IPD Sharing: YES. Countries: 2. Publications: 1.
Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions
ClinicalTrials.gov study NCT00407355. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) Study
ClinicalTrials.gov study NCT00407381. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement
ClinicalTrials.gov study NCT00284050. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.